PRIMARY STUDY
In Vitro Evaluation of the Activity of Terpenes and Cannabidiol against Human Coronavirus E229
Key Findings: Secondary cannabis compounds such as terpenes have been shown to have significant antiviral potential and low toxicity, making them good candidates for use as antiviral agents with minimal side effects. The combination of NT-VRL-1 (a proprietary terpene formulation) with CBD may have an antiviral effect against human coronaviruses.
Type of Study: Laboratory Study
Study Result: Positive
Research Location(s): Israel
Year of Pub: 2021
Cannabinoids Studied: Cannabidiol (CBD), Cannabinoid (unspecified)
Phytocannabinoid Source: Unspecified
Terpenes Studied: ß-Caryophyllene, Eucalyptol
Route of Administration: In vitro
Citation: Chatow L, et al. In Vitro Evaluation of the Activity of Terpenes and Cannabidiol against Human Coronavirus E229. Life (Basel). 2021; 11:(unknown pages). doi: 10.3390/life11040290
Authors: Chatow L, Nudel A, Nesher I, Hayo Hemo D, Rozenberg P, Voropaev H, Winkler I, Levy R, Kerem Z, Yaniv Z, Eyal N
